1. Lung Transplantation in Gaucher Disease
Geertje M. de Boer, BSc, Laura van Dussen, MD, PhD, Leon M. van den Toorn, MD, PhD, Michael A. den Bakker, MD, PhD, Rogier A.S. Hoek, MD, Dennis A. Hesselink, MD, PhD, Carla E.M. Hollak, MD, PhD, Peter Th. W. van Hal, MD, PhD 
CHEST 
Volume 149, Issue 1, Pages e1-e5 (January 2016)
DOI: /j.chest
Copyright © 2016 American College of Chest Physicians Terms and Conditions

2. Figure 1
Pulmonary tissue, (hematoxylin and eosin stain, original magnification ×10) from the explanted lungs from the patient in our study with Gaucher disease and severe pulmonary hypertension. There are vascular changes with intimal thickening and medial hypertrophy of small centrilobular pulmonary arteries consistent with pulmonary hypertension. The insert (hematoxylin and eosin stain, original magnification ×40) shows a cluster of Gaucher cells in the pulmonary alveolar interstitium.
CHEST  , e1-e5DOI: ( /j.chest )
Copyright © 2016 American College of Chest Physicians Terms and Conditions

3. Figure 2
Estimated glomerular filtration (eGFR) rates pretransplantation and posttransplantation. The time scale and renal function are given on the abscissa and ordinate, respectively. The declining eGFR improved initially after lung transplantation (arrow 1), although a gradual decrease was noticed a few months later. After kidney transplantation (arrow 2), eGFR improved significantly.
CHEST  , e1-e5DOI: ( /j.chest )
Copyright © 2016 American College of Chest Physicians Terms and Conditions